CVRx Appoints John Landry as CFO with $500K Salary and 0.80% Equity Grant
CVRX sits 35% above its 52-week low of $2.2 on light trading volume (0.4× avg).
Summary
CVRx appointed John Landry as CFO effective October 12, 2026, with a $500,000 salary, 50% target bonus, and equity awards representing 0.80% of outstanding shares. He succeeds Jared Oasheim, whose resignation was previously announced.
Key Events · Executive and Board Changes · CVRX
-
New CFO Appointed
John Landry has been appointed CFO, succeeding Jared Oasheim. Landry joins on October 12, 2026, and assumes CFO duties the day after the Q3 2026 Form 10-Q filing, expected in early November 2026.
-
Compensation Package
Landry will receive a $500,000 annual base salary, a 50% target cash bonus pro-rated for fiscal 2026, and equity awards representing 0.80% of outstanding shares, split 75% stock options and 25% RSUs at a 1.5:1 multiple.
-
Leadership Transition
Oasheim's resignation was previously disclosed on June 8, 2026. He will remain for a transition period consistent with his transition agreement.
-
Activist Pressure Context
The appointment follows activist investor Jorey Chernett's August 2026 demand for a sale process and a securities fraud investigation announced by Hagens Berman in August 2026.
Analysis · CVRX · Industrial Applications And Services
CVRx has appointed John Landry as its new CFO, filling a critical leadership gap left by the prior CFO's resignation in June. Landry brings two decades of medtech finance experience, including CFO roles at Nyxoah and Vapotherm. His compensation package includes a $500,000 base salary, a 50% target bonus, and equity awards representing 0.80% of outstanding shares. The appointment comes amid activist pressure for a sale process and a recent securities fraud investigation, making the CFO hire a key step in stabilizing the company's financial leadership.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CVRX was trading at $2.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $79.1M. The 52-week trading range was $2.20 to $11.30. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.